These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6792644)

  • 1. Investigation of the mechanism of action of prostaglandin synthesis inhibitors on renin and aldosterone secretion and sodium excretion.
    Papanicolaou N; Papadakis G; Papanicolaou P; Theodorakopoulos P; Paris M; Dontas A; Paris M; Bariety J; Milliez P
    Prostaglandins Med; 1981 Aug; 7(2):163-81. PubMed ID: 6792644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is low urinary prostaglandin concentration a stage in the development of essential hypertension?
    Papanicolaou N; Safar M; Tsapara-Stavroulaki A; Baskiotis C; Lefkos N; Paris M; Marketos S; Bariéty J; Dontas A; Milliez P
    Prostaglandins Med; 1979 Jul; 3(1):53-67. PubMed ID: 399528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of plasma renin activity by indomethacin in man.
    Frölich JC; Hollifield JW; Dormois JC; Frölich BL; Seyberth H; Michelakis AM; Oates JA
    Circ Res; 1976 Sep; 39(3):447-52. PubMed ID: 821675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of urinary PGE2 and renin-angiotensin-aldosterone system in the pathogenesis of essential hypertension.
    Ruilope L; Garcia Robles R; Barrientos A; Bernis C; Alcazar J; Tresguerres JA; Mancheño E; Millet VG; Sancho J; Rodicio JL
    Clin Exp Hypertens A; 1982; 4(6):989-1000. PubMed ID: 7047008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of plasma renin activity by inhibition of the fatty acid cyclooxygenase in human subjects: independence of sodium retention.
    Frölich JC; Hollifield JW; Michelakis AM; Vesper BS; Wilson JP; Shand DG; Seyberth HJ; Frölich WH; Oates JA
    Circ Res; 1979 Jun; 44(6):781-7. PubMed ID: 218749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of propranolol on the urinary excretion of prostaglandin E and plasma renin activity in hypertensive patients.
    Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Sato K; Imai Y; Sakurai Y; Ito T; Omata K; Yoshinaga K
    Prostaglandins Med; 1980 Jul; 5(1):1-9. PubMed ID: 6996018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of indomethacin on plasma renin activity, plasma aldosterone concentration, urinary prostaglandin E excretion and blood pressure in patients with essential hypertension.
    Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Imai Y; Saito K; Sakurai Y; Ito T; Ritsu K; Haruyama T; Otsuka Y; Yoshinaga K
    Tohoku J Exp Med; 1979 May; 128(1):31-7. PubMed ID: 452004
    [No Abstract]   [Full Text] [Related]  

  • 9. Dissociation of renin--aldosterone and renal prostaglandin E during volume expansion induced by immersion in normal man.
    Epstein M; Lifschitz MD; Re R; Haber E
    Clin Sci (Lond); 1980 Jul; 59(1):55-62. PubMed ID: 7009025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indomethacin blockade of renal PGE-synthesis: effect on total renal and tubular function and plasma renin concentration in hydropenic rats and on their response to isotonic saline.
    Leyssac PP; Christensen P; Hill R; Skinner SL
    Acta Physiol Scand; 1975 Aug; 94(4):484-96. PubMed ID: 1180089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of indomethacin on the renal function and renin-aldosterone system in chronic glomerulonephritis.
    Kutyrina IM; Androsova SO; Warshavskii VA; Tareyeva IE
    Nephron; 1982; 32(3):244-8. PubMed ID: 6759952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of renal prostaglandin E2 in chronic renal disease hypertension.
    Ruilope L; Garcia Robles P; Bernis C; Barrientos A; Alcazar J; Tresguerres JA; Sancho J; Rodicio JL
    Nephron; 1982; 32(3):202-6. PubMed ID: 6759949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers.
    Stichtenoth DO; Marhauer V; Tsikas D; Gutzki FM; Frölich JC
    Kidney Int; 2005 Nov; 68(5):2197-207. PubMed ID: 16221219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary prostaglandin and sodium metabolism in patients with essential hypertension.
    Yasujima N; Abe K; Irokawa N; Chiba S; Sato M; Seino M; Sakurai Y; Saito K; Ito T; Ritsu K; Yoshinaga K
    Tohoku J Exp Med; 1978 Mar; 124(3):277-83. PubMed ID: 635902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral determinants of Na+ excretion after intravenous NaCl loading in normal volunteers.
    Stokes GS; Johnston HJ; Monaghan JC
    Clin Exp Pharmacol Physiol; 1993 May; 20(5):310-2. PubMed ID: 8324915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hypervolemia and renin in the blood pressure control of patients with pyelonephritis renal scarring.
    Jacobson SH; Kjellstrand CM; Lins LE
    Acta Med Scand; 1988; 224(1):47-53. PubMed ID: 3046233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic infusion of atrial natriuretic factor on plasma and urinary aldosterone, plasma renin activity, blood pressure and sodium excretion in 2-K, 1-C hypertensive rats.
    Garcia R; Thibault G; Gutkowska J; Cantin M
    Clin Exp Hypertens A; 1986; 8(7):1127-47. PubMed ID: 2945679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of prostaglandins in the control of renin secretion in the dog.
    Yun J; Kelly G; Bartter FC; Smith H
    Circ Res; 1977 May; 40(5):459-64. PubMed ID: 852103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 1-Sar-8-Ile-angiotensin II on urinary prostaglandin excretion in patients with essential hypertension.
    Yasujima M; Abe K; Otsuka Y; Chiba S; Ritsu K; Irokawa N; Seino M; Sakurai Y; Saito K; Ito T; Yoshinaga K
    Tohoku J Exp Med; 1977 Nov; 123(3):271-8. PubMed ID: 601775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.
    Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Sørensen SS; Pedersen EB
    Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.